Regenxbio
RGNX

股本结构

单位：万股
公告日期 2025-11-06 2025-11-26 2025-08-07 2025-08-07 2025-06-13 2025-05-12
证券总股本 5062.31 5061.87 5051.42 5038.90 5038.87 5016.04
普通股本 5062.31 5061.87 5051.42 5038.90 5038.87 5016.04
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-10-31 2025-09-30 2025-07-31 2025-06-30 2025-06-09 2025-05-08
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2025-11-06 5062.31 未披露 定期报告 2025-10-31
2025-11-26 5061.87 未披露 定期报告 2025-09-30
2025-08-07 5051.42 未披露 定期报告 2025-07-31
2025-08-07 5038.90 未披露
更多>>
From March 31, 2025 to June 30, 2025 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Exercise of pre-funded warrants
2025-06-30
2025-06-13 5038.87 未披露 定期报告 2025-06-09
2025-05-12 5016.04 未披露 定期报告 2025-05-08
2025-04-08 5011.69 未披露 定期报告 2025-04-01
2025-05-12 5011.70 未披露
更多>>
From December 31, 2024 to March 31, 2025 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Issuance of common stock under employee stock purchase plan
2025-03-31
2025-03-13 5008.61 未披露 定期报告 2025-03-07
2025-03-13 4954.90 未披露
更多>>
From December 31, 2023 to December 31, 2024 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Issuance of common stock under employee stock purchase plan Issuance of common stock and pre-funded warrants upon public offering, net of transaction costs of $534 Exercise of pre-funded warrants
2024-12-31
2024-11-06 4954.51 未披露 定期报告 2024-10-31
2024-12-09 4953.41 未披露
更多>>
From June 30, 2024 to September 30, 2024 Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan Exercise of stock options, net of tax
2024-09-30
2024-08-01 4942.32 未披露 定期报告 2024-07-25
2024-08-01 4931.70 未披露
更多>>
From March 31, 2024 to June 30, 2024 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Exercise of pre-funded warrants
2024-06-30
2024-05-08 4925.60 未披露 定期报告 2024-05-02
2024-04-04 4904.27 未披露 定期报告 2024-04-01
2024-05-08 4904.30 未披露
更多>>
From December 31, 2023 to March 31, 2024 Exercise of stock options, net of tax Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan Issuance of common stock and pre-funded warrants upon public offering, net of transaction costs of $534
2024-03-31
2024-03-08 4899.28 未披露
更多>>
Common stock offered 4,565,260 shares by the company
2024-03-11
2024-02-27 4442.76 未披露 定期报告 2024-02-22
2024-03-08 4404.62 未披露
更多>>
From December 31,2022 to December 31,2023 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Issuance of common stock under employee stock purchase plan Issuance of common stock upon private placement,net of transaction costs of $126
2023-12-31
2023-11-08 4399.20 未披露 定期报告 2023-11-02
2023-11-08 4399.10 未披露
更多>>
From June 30, 2023 to September 30, 2023 Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan Issuance of common stock upon private placement, net of transaction costs of $126 Exercise of stock options, net of tax
2023-09-30
2023-09-01 4396.11 未披露 定期报告 2023-08-30
2023-08-02 4396.01 未披露 定期报告 2023-07-27
2023-08-02 4362.10 未披露
更多>>
From March 31, 2023 to June 30, 2023 Exercise of stock options, net of tax Vesting of restricted stock units, net of tax
2023-06-30
2023-05-03 4346.62 未披露 定期报告 2023-04-27
2023-04-06 4346.52 未披露 定期报告 2023-04-03
2023-05-03 4346.50 未披露
更多>>
From December 31, 2022 to March 31, 2023 Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan Exercise of stock options, net of tax
2023-03-31
2023-02-28 4346.37 未披露 定期报告 2023-02-23
2023-02-28 4329.90 未披露
更多>>
From December 31, 2021 to December 31, 2022 Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan Exercise of stock options, net of tax
2022-12-31
2022-11-03 4329.36 未披露 定期报告 2022-10-27
2024-12-09 4329.23 未披露
更多>>
From June 30, 2022 to September 30, 2022 Exercise of stock options, net of tax Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan
2022-09-30
2022-08-03 4323.00 未披露 定期报告 2022-07-27
2022-08-03 4317.10 未披露
更多>>
From March 31, 2022 to June 30, 2022 Exercise of stock options, net of tax Vesting of restricted stock units, net of tax
2022-06-30
2022-05-04 4313.39 未披露 定期报告 2022-04-28
2022-04-07 4298.55 未披露 定期报告 2022-04-04
2022-05-04 4298.20 未披露
更多>>
From December 31, 2021 to March 31, 2022 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Issuance of common stock under employee stock purchase plan
2022-03-31
2022-03-01 4294.96 未披露 定期报告 2022-02-24
2022-03-01 4283.10 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock upon public offering, net of transaction costs of $14,194 Exercise of stock options, net of tax Issuance of common stock under employee stock purchase plan
2021-12-31
2021-11-02 4276.92 未披露 定期报告 2021-10-28
2021-11-02 4275.20 未披露
更多>>
From June 30, 2021 to September 30, 2021 Exercise of stock options Issuance of common stock under employee stock purchase plan
2021-09-30
2021-08-09 4260.05 未披露 定期报告 2021-08-04
2021-08-09 4255.50 未披露
更多>>
From March 31, 2021 to June 30, 2021 Exercise of stock options
2021-06-30
2021-05-05 4250.94 未披露 定期报告 2021-04-30
2021-04-19 4250.51 未披露 定期报告 2021-04-05
2021-05-05 4250.50 未披露
更多>>
from December 31, 2020 to March 31, 2021 Issuance of common stock upon public offering, net of transaction costs of $14,194 Exercise of stock options Issuance of common stock under employee stock purchase plan
2021-03-31
2021-03-01 4249.85 未披露 定期报告 2021-02-25
2021-01-12 4166.42 未披露
更多>>
1.Common stock offered by the company 4,260,000 shares of common stock. 2.The number of shares of common stock to be outstanding immediately after this offering, as stated above, is based on 37,404,204 shares outstanding as of September 30, 2020.
2021-01-12
2021-03-01 3747.60 未披露
更多>>
from December 31, 2019 to December 31, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan
2020-12-31
2020-11-04 3740.84 未披露 定期报告 2020-10-30
2021-01-06 3740.42 未披露
更多>>
From June 30, 2020 to September 30, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan
2020-09-30
2020-08-06 3733.40 未披露 定期报告 2020-07-31
2020-08-06 3729.10 未披露
更多>>
From March 31, 2020 to June 30, 2020 Exercise of stock options
2020-06-30
2020-05-07 3724.11 未披露 定期报告 2020-05-01
2020-05-07 3719.00 未披露
更多>>
From December 31, 2019 to March 31, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan
2020-03-31
2020-04-08 3718.62 未披露 定期报告 2020-03-30
2020-02-26 3713.92 未披露 定期报告 2020-02-21
2020-02-26 3699.20 未披露
更多>>
from December 31, 2018 to December 31, 2019 Vesting of restricted stock units Issuance of common stock under employee stock purchase plan Exercise of stock options
2019-12-31
2019-11-05 3687.43 未披露 定期报告 2019-11-01
2019-11-05 3684.00 未披露
更多>>
from June 30, 2019 to September 30, 2019 Exercise of stock options Issuance of common stock under employee stock purchase plan
2019-09-30
2019-08-07 3680.66 未披露 定期报告 2019-08-02
2019-08-07 3675.20 未披露
更多>>
from December 31, 2018 to June 30, 2019 Exercise of stock options Issuance of common stock under employee stock purchase plan
2019-06-30
2019-05-07 3663.68 未披露 定期报告 2019-05-03
2019-04-11 3661.12 未披露 定期报告 2019-04-01
2019-05-07 3661.10 未披露
更多>>
from December 31, 2018 to March 31, 2019 Exercise of stock options Issuance of common stock under employee stock purchase plan
2019-03-31
2019-02-27 3641.87 未披露 定期报告 2019-02-22
2019-02-27 3612.00 未披露
更多>>
from December 31, 2017 to December 31, 2018 Issuance of common stock upon public offering, net of transaction costs of $12,728 Exercise of stock options Issuance of common stock under employee stock purchase plan
2018-12-31
2018-11-07 3584.04 未披露 定期报告 2018-11-02
2018-11-07 3570.40 未披露 定期报告 2018-09-30
2018-08-10 3497.47 未披露 定期报告 2018-08-09
2018-08-08 3230.86 未披露 定期报告 2018-08-03
2018-08-08 3227.50 未披露 定期报告 2018-06-30
2018-05-08 3193.60 未披露 定期报告 2018-05-04
2018-05-08 3190.00 未披露 定期报告 2018-03-31
2018-04-12 3187.06 未披露 定期报告 2018-03-26
2018-03-06 3165.51 未披露 定期报告 2018-03-02
2018-03-06 3129.50 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock upon public offering, net of transaction costs of $5,738 Exercise of stock options Issuance of common stock under employee stock purchase plan
2017-12-31
2017-11-08 3114.53 未披露 定期报告 2017-11-03
2017-11-08 3110.90 未披露 定期报告 2017-09-30
2017-08-25 3094.89 未披露 定期报告 2017-08-23
2017-08-08 3089.44 未披露 定期报告 2017-08-04
2017-08-08 3085.30 未披露 定期报告 2017-06-30
2017-05-09 3082.14 未披露 定期报告 2017-05-05
2017-05-09 3024.40 未披露 定期报告 2017-03-31
2017-04-13 3023.49 未披露 定期报告 2017-03-27
2017-03-07 2651.33 未披露 定期报告 2017-03-03
2017-03-07 2647.66 未披露
更多>>
from December 31, 2015 to December 31, 2016 Exercise of stock options
2016-12-31
2016-12-16 2647.96 未披露 定期报告 2016-12-15
2016-11-09 2647.54 未披露 定期报告 2016-09-30
2016-08-09 2646.54 未披露 定期报告 2016-08-05
2016-08-09 2646.30 未披露 定期报告 2016-06-30
2016-05-05 2633.83 未披露 定期报告 2016-04-04
2016-05-05 2633.80 未披露 定期报告 2016-03-31
2016-03-03 2632.86 未披露 定期报告 2016-03-01
2016-03-03 2631.30 未披露
更多>>
from December 31, 2014 to December 31, 2015 Conversion of convertible preferred stock into common stock upon initial public offering Issuance of common stock upon initial public offering, net of transaction costs of $14,206 Exercise of stock options Issuance of Series C convertible preferred stock, net of transaction costs of $187 Issuance of Series C convertible preferred stock for the conversion of outstanding related party debt Issuance of Series D convertible preferred stock, net of transaction costs of $2,502 Loss (gain) on extinguishment of convertible preferred stock Accretion (decretion) of convertible preferred stock
2015-12-31
2015-11-05 2631.35 未披露 定期报告 2015-11-05
2015-11-05 2630.60 未披露 定期报告 2015-09-30
2015-09-17 2535.07 未披露
更多>>
the automatic conversion of all outstanding shares of our convertible preferred stock into 16,298,045 shares of common stock, upon the completion of this offering
2015-09-17
2015-08-17 275.27 1629.80
更多>>
from December 31, 2014 to June 30, 2015 Issuance of Series C convertible preferred stock, net of transaction costs of $187 (unaudited) Issuance of Series C convertible preferred stock, for the conversion of outstanding related party debt (unaudited) Issuance of Series D convertible preferred stock, net of transaction costs of $2,502 (unaudited) Loss (gain) on extinguishment of convertible preferred stock (unaudited) Accretion (decretion) of convertible preferred stock (unaudited) Exercise of stock options (unaudited)
2015-06-30
From March 31, 2025 to June 30, 2025 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Exercise of pre-funded warrants
From December 31, 2024 to March 31, 2025 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Issuance of common stock under employee stock purchase plan
From December 31, 2023 to December 31, 2024 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Issuance of common stock under employee stock purchase plan Issuance of common stock and pre-funded warrants upon public offering, net of transaction costs of $534 Exercise of pre-funded warrants
From June 30, 2024 to September 30, 2024 Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan Exercise of stock options, net of tax
From March 31, 2024 to June 30, 2024 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Exercise of pre-funded warrants
From December 31, 2023 to March 31, 2024 Exercise of stock options, net of tax Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan Issuance of common stock and pre-funded warrants upon public offering, net of transaction costs of $534
Common stock offered 4,565,260 shares by the company
From December 31,2022 to December 31,2023 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Issuance of common stock under employee stock purchase plan Issuance of common stock upon private placement,net of transaction costs of $126
From June 30, 2023 to September 30, 2023 Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan Issuance of common stock upon private placement, net of transaction costs of $126 Exercise of stock options, net of tax
From March 31, 2023 to June 30, 2023 Exercise of stock options, net of tax Vesting of restricted stock units, net of tax
From December 31, 2022 to March 31, 2023 Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan Exercise of stock options, net of tax
From December 31, 2021 to December 31, 2022 Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan Exercise of stock options, net of tax
From June 30, 2022 to September 30, 2022 Exercise of stock options, net of tax Vesting of restricted stock units, net of tax Issuance of common stock under employee stock purchase plan
From March 31, 2022 to June 30, 2022 Exercise of stock options, net of tax Vesting of restricted stock units, net of tax
From December 31, 2021 to March 31, 2022 Vesting of restricted stock units, net of tax Exercise of stock options, net of tax Issuance of common stock under employee stock purchase plan
From December 31, 2020 to December 31, 2021 Issuance of common stock upon public offering, net of transaction costs of $14,194 Exercise of stock options, net of tax Issuance of common stock under employee stock purchase plan
From June 30, 2021 to September 30, 2021 Exercise of stock options Issuance of common stock under employee stock purchase plan
From March 31, 2021 to June 30, 2021 Exercise of stock options
from December 31, 2020 to March 31, 2021 Issuance of common stock upon public offering, net of transaction costs of $14,194 Exercise of stock options Issuance of common stock under employee stock purchase plan
1.Common stock offered by the company 4,260,000 shares of common stock. 2.The number of shares of common stock to be outstanding immediately after this offering, as stated above, is based on 37,404,204 shares outstanding as of September 30, 2020.
from December 31, 2019 to December 31, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan
From June 30, 2020 to September 30, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan
From March 31, 2020 to June 30, 2020 Exercise of stock options
From December 31, 2019 to March 31, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan
from December 31, 2018 to December 31, 2019 Vesting of restricted stock units Issuance of common stock under employee stock purchase plan Exercise of stock options
from June 30, 2019 to September 30, 2019 Exercise of stock options Issuance of common stock under employee stock purchase plan
from December 31, 2018 to June 30, 2019 Exercise of stock options Issuance of common stock under employee stock purchase plan
from December 31, 2018 to March 31, 2019 Exercise of stock options Issuance of common stock under employee stock purchase plan
from December 31, 2017 to December 31, 2018 Issuance of common stock upon public offering, net of transaction costs of $12,728 Exercise of stock options Issuance of common stock under employee stock purchase plan
from December 31, 2016 to December 31, 2017 Issuance of common stock upon public offering, net of transaction costs of $5,738 Exercise of stock options Issuance of common stock under employee stock purchase plan
from December 31, 2015 to December 31, 2016 Exercise of stock options
from December 31, 2014 to December 31, 2015 Conversion of convertible preferred stock into common stock upon initial public offering Issuance of common stock upon initial public offering, net of transaction costs of $14,206 Exercise of stock options Issuance of Series C convertible preferred stock, net of transaction costs of $187 Issuance of Series C convertible preferred stock for the conversion of outstanding related party debt Issuance of Series D convertible preferred stock, net of transaction costs of $2,502 Loss (gain) on extinguishment of convertible preferred stock Accretion (decretion) of convertible preferred stock
the automatic conversion of all outstanding shares of our convertible preferred stock into 16,298,045 shares of common stock, upon the completion of this offering
from December 31, 2014 to June 30, 2015 Issuance of Series C convertible preferred stock, net of transaction costs of $187 (unaudited) Issuance of Series C convertible preferred stock, for the conversion of outstanding related party debt (unaudited) Issuance of Series D convertible preferred stock, net of transaction costs of $2,502 (unaudited) Loss (gain) on extinguishment of convertible preferred stock (unaudited) Accretion (decretion) of convertible preferred stock (unaudited) Exercise of stock options (unaudited)
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。